10.1007/s40097-022-00519-9

PLGA microparticle formulations for tunable delivery of a nano-engineered filamentous bacteriophage-based vaccine: in vitro and in silico-supported approach

Show Details XML PDF
  • Rezvan Jamaledin1,
  • Rossella Sartorius2,
  • Concetta Di Natale3,
  • Valentina Onesto4,
  • Roberta Manco2,
  • Valentina Mollo4,
  • Raffaele Vecchione*4,
  • Piergiuseppe De Berardinis2,
  • Paolo Antonio Netti3,
  1. Center for Advanced Biomaterials for Health Care (CABHC), Istituto Italiano di Tecnologia, Naples, IT School of Engineering, Institute for Bioengineering, The University of Edinburgh, Edinburgh, GB
  2. Institute of Biochemistry and Cell Biology (IBBC), CNR, Naples, 80131, IT
  3. Center for Advanced Biomaterials for Health Care (CABHC), Istituto Italiano di Tecnologia, Naples, IT Interdisciplinary Research Centre On Biomaterials (CRIB), University of Naples Federico II, Naples, IT Department of Chemical Materials and Industrial Production (DICMAPI), University of Naples Federico II, Naples, IT
  4. Center for Advanced Biomaterials for Health Care (CABHC), Istituto Italiano di Tecnologia, Naples, IT
PLGA microparticle formulations for tunable delivery of a nano-engineered filamentous bacteriophage-based

Published in Issue 11-01-2023

Copyright (c) 2025 Rezvan Jamaledin, Rossella Sartorius, Concetta Di Natale, Valentina Onesto, Roberta Manco, Valentina Mollo, Raffaele Vecchione, Piergiuseppe De Berardinis, Paolo Antonio Netti (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Jamaledin, R., Sartorius, R., Di Natale, C., Onesto, V., Manco, R., Mollo, V., Vecchione, R., De Berardinis, P., & Netti, P. A. (2023). PLGA microparticle formulations for tunable delivery of a nano-engineered filamentous bacteriophage-based vaccine: in vitro and in silico-supported approach. Journal of Nanostructure in Chemistry, 14(5). https://doi.org/10.1007/s40097-022-00519-9
Crossref
Scopus
Google Scholar
Europe PMC

PDF views: 290

Abstract

Abstract Bacteriophages have attracted great attention in the bioengineering field in diverse research areas from tissue engineering to therapeutic and clinical applications. Recombinant filamentous bacteriophage, carrying multiple copies of foreign peptides on protein capsid has been successfully used in the vaccine delivery setting, even if their plasma instability and degradation have limited their use on the pharmaceutical market. Encapsulation techniques in polymeric materials can be applied to preserve bacteriophage activity, extend its half-life, and finely regulate their release in the target environment. The main goal of this study was to provide tunable formulations of the bacteriophage encapsulated in polymeric microparticles (MPs). We used poly (lactic-co-glycolic-acid) as a biocompatible and biodegradable polymer with ammonium bicarbonate as a porogen to encapsulate bacteriophage expressing OVA (257–264) antigenic peptide. We demonstrate that nano-engineered fdOVA bacteriophages encapsulated in MPs preserve their structure and are immunologically active, inducing a strong immune response towards the delivered peptide. Moreover, MP encapsulation prolongs bacteriophage stability over time also at room temperature. Additionally, in this study, we show the ability of in silico-supported approach to predict and tune the release of bacteriophages. These results lay the framework for a versatile bacteriophage-based vaccine delivery system that could successfully generate robust immune responses in a sustained manner, to be used as a platform against cancer and new emerging diseases. Graphical abstract Synopsis: administration of recombinant bacteriophage-loaded PLGA microparticles for antigen delivery. PLGA microparticles release the bacteriophages, inducing activation of dendritic cells and enhancing antigen presentation and specific T cell response. Bacteriophage-encapsulated microneedles potentially can be administered into human body and generate robust immune responses.

Keywords

  • Controlled release,
  • Immune responses,
  • In silico,
  • Phage display,
  • Vaccination,
  • Nano-engineered bacteriophage
PDF

References

  1. Sartorius et al. (2015) Antigen delivery by filamentous bacteriophage fd displaying an anti- DEC -205 single-chain variable fragment confers adjuvanticity by triggering a TLR 9-mediated immune response (pp. 973-988) https://doi.org/10.15252/emmm.201404525
  2. Sartorius et al. (2011) Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants (pp. 2573-2584) https://doi.org/10.1002/eji.201141526
  3. Sartorius et al. (2018) Vectorized delivery of alpha-Galactosylceramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor-specific T cell response https://doi.org/10.3389/fimmu.2018.01496
  4. Murgas et al. (2018) A filamentous bacteriophage targeted to carcinoembryonic antigen induces tumor regression in mouse models of colorectal cancer (pp. 183-193) https://doi.org/10.1007/s00262-017-2076-x
  5. Staquicini, D.I., Tang, F.H.F., Markosian, C., Yao, V.J., Staquicini, F.I., Dodero-Rojas, E., Contessoto, V.G., Davis, D., O’ Brien, P., Habib, N.: Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain. Proc. Natl. Acad. Sci.
  6. 118,
  7. (2021).
  8. Dubey et al. (2022) Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases (pp. 833-864) https://doi.org/10.1007/s40097-022-00472-7
  9. de da Barros, A.O.S., Pinto, S.R., dos Reis, S.R.R., Ricci-Junior, E., Alencar, L.M.R., Bellei, N.C.J., Janini, L.R.M., Maricato, J.T., Rosa, D.S., Santos-Oliveira, R.: Polymeric nanoparticles and nanomicelles of hydroxychloroquine co-loaded with azithromycin potentiate anti-SARS-CoV-2 effect. J. Nanostruct. Chem. 1–19 (2022).
  10. https://doi.org/10.1007/s40097-022-00476-3
  11. Sartorius et al. (2019) Arming filamentous bacteriophage, a nature-made nanoparticle, for new vaccine and immunotherapeutic strategies https://doi.org/10.3390/pharmaceutics11090437
  12. Stern et al. (2019) The development of inovirus-associated vector vaccines using phage-display technologies (pp. 913-920) https://doi.org/10.1080/14760584.2019.1651649
  13. Jamaledin et al. (2020) Recombinant filamentous bacteriophages encapsulated in biodegradable polymeric microparticles for stimulation of innate and adaptive immune responses https://doi.org/10.3390/microorganisms8050650
  14. González-Mora et al. (2020) Bacteriophage-based vaccines: a potent approach for antigen delivery https://doi.org/10.3390/vaccines8030504
  15. Bartolacci et al. (2018) Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer (pp. 1486-1498) https://doi.org/10.1158/2326-6066.CIR-18-0179
  16. Wang et al. (2021) Filamentous bacteriophage—a powerful carrier for glioma therapy
  17. Foglizzo and Marchiò (2021) Bacteriophages as therapeutic and diagnostic vehicles in cancer https://doi.org/10.3390/ph14020161
  18. Malek-Khatabi et al. (2022) Long-Term Vaccine Delivery and Immunological Responses Using Biodegradable Polymer-Based Carriers (pp. 5015-5040) https://doi.org/10.1021/acsabm.2c00638
  19. Di Natale et al. (2020) Perspectives in peptide-based vaccination strategies for syndrome coronavirus 2 pandemic https://doi.org/10.3389/fphar.2020.578382
  20. Jamaledin et al. (2020) Engineered microneedle patches for controlled release of active compounds: recent advances in release profile tuning https://doi.org/10.1002/adtp.202000171
  21. Li et al. (2019) Composition design and medical application of liposomes (pp. 640-653) https://doi.org/10.1016/j.ejmech.2019.01.007
  22. Colom et al. (2017) Microencapsulation with alginate/CaCO 3: a strategy for improved phage therapy (pp. 1-10) https://doi.org/10.1038/srep41441
  23. Zare et al. (2020) Metal-based nanostructures/PLGA nanocomposites: antimicrobial activity, cytotoxicity, and their biomedical applications (pp. 3279-3300) https://doi.org/10.1021/acsami.9b19435
  24. Malik et al. (2017) Formulation, stabilisation and encapsulation of bacteriophage for phage therapy (pp. 100-133) https://doi.org/10.1016/j.cis.2017.05.014
  25. Battisti et al. (2019) Non-invasive production of multi-compartmental biodegradable polymer microneedles for controlled intradermal drug release of labile molecules https://doi.org/10.3389/fbioe.2019.00296
  26. Wójcik-Pastuszka et al. (2019) Evaluation of the release kinetics of a pharmacologically active substance from model intra-articular implants replacing the cruciate ligaments of the knee https://doi.org/10.3390/ma12081202
  27. Mircioiu et al. (2019) Mathematical modeling of release kinetics from supramolecular drug delivery systems https://doi.org/10.3390/pharmaceutics11030140
  28. Jakhmola et al. (2019) Experimental and theoretical study of biodirected green synthesis of gold nanoflowers https://doi.org/10.1016/j.mtchem.2019.100203
  29. Bruschi (2015) Woodhead Publishing
  30. Dash et al. (2010) Kinetic modeling on drug release from controlled drug delivery systems (pp. 217-223)
  31. Del Pozzo et al. (2010) Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses
  32. Di Natale et al. (2020) Tunable release of curcumin with an in silico-supported approach from mixtures of highly porous PLGA microparticles (pp. 1807-1808) https://doi.org/10.3390/ma13081807
  33. Di Natale et al. (2021) Design of biodegradable bi-compartmental microneedles for the stabilization and the controlled release of the labile molecule collagenase for skin healthcare (pp. 392-403) https://doi.org/10.1039/D0TB02279A
  34. Profeta et al. (2021) Cell membrane-coated oil in water nano-emulsions as biomimetic nanocarriers for lipophilic compounds conveyance https://doi.org/10.3390/pharmaceutics13071069
  35. Di Natale et al. (2018) Molecularly endowed hydrogel with an in silico-assisted screened peptide for highly sensitive small molecule harvesting (pp. 10088-10091) https://doi.org/10.1039/C8CC04943B
  36. Celetti et al. (2016) Functionalized poly (ethylene glycol) diacrylate microgels by microfluidics: in situ peptide encapsulation for in serum selective protein detection (pp. 21-29) https://doi.org/10.1016/j.colsurfb.2016.04.036
  37. Di Natale, C., Battista, E., Lettera, V., Reddy, N., Pitingolo, G., Vecchione, R., Causa, F., Netti, P.A.: Easy surface functionalization and bioconjugation of peptides as capture agents of a microfluidic biosensing platform for multiplex assay in serum. Bioconjug. Chem.
  38. 32.8,
  39. –1601 (2021)
  40. Di Natale et al. (2019) Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia (pp. 637-644) https://doi.org/10.1016/j.bbapap.2019.01.010
  41. Fotticchia et al. (2017) Enhanced drug delivery into cell cytosol via glycoprotein H-derived peptide conjugated nanoemulsions (pp. 9802-9813) https://doi.org/10.1021/acsnano.7b03058
  42. Di Natale et al. (2020) Effects of surface nanopatterning on internalization and amyloid aggregation of the fragment 264–277 of nucleophosmin 1 https://doi.org/10.1016/j.colsurfb.2020.111439
  43. Di Natale et al. (2020) Proteostasis unbalance of nucleophosmin 1 in acute myeloid leukemia: an aggregomic perspective (pp. 3501-3507) https://doi.org/10.1016/j.ijbiomac.2020.08.248
  44. Florio et al. (2021) Self-assembly of bio-inspired heterochiral peptides https://doi.org/10.1016/j.bioorg.2021.105047
  45. Olofsson et al. (2001) Filamentous bacteriophage stability in non-aqueous media (pp. 661-671) https://doi.org/10.1016/S1074-5521(01)00041-2
  46. Rakonjac et al. (2017) Filamentous phage: structure and biology (pp. 1-20) Springer
  47. Berardinis et al. (2003) Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection (pp. 441-446) https://doi.org/10.2174/1570162033485168
  48. Lee and Yeo (2015) Controlled drug release from pharmaceutical nanocarriers (pp. 75-84) https://doi.org/10.1016/j.ces.2014.08.046
  49. Rabiee et al. (2021) Calcium-based nanomaterials and their interrelation with chitosan: optimization for pCRISPR delivery https://doi.org/10.1007/s40097-021-00446-1
  50. Tabasi et al. (2021) Metal–polymer-coordinated complexes as potential nanovehicles for drug delivery (pp. 501-526) https://doi.org/10.1007/s40097-021-00432-7
  51. Zafar et al. (2023) T-cell membrane-functionalized nanosystems for viral infectious diseases
  52. Raza et al. (2022) T-cell membrane-coated nanomaterials in cancer treatment (pp. 199-217)
  53. Movagharnezhad et al. (2022) Synthesis of poly (N-vinylpyrrolidone)-grafted-magnetite bromoacetylated cellulose via ATRP for drug delivery (pp. 89-98)
  54. Yousefiasl et al. (2022) Chitosan/alginate bionanocomposites adorned with mesoporous silica nanoparticles for bone tissue engineering https://doi.org/10.1007/s40097-022-00507-z
  55. Allahyari and Mohit (2016) Peptide/protein vaccine delivery system based on PLGA particles (pp. 806-828) https://doi.org/10.1080/21645515.2015.1102804
  56. Silva et al. (2016) PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity (pp. 1056-1069) https://doi.org/10.1080/21645515.2015.1117714
  57. Lagreca et al. (2020) Recent advances in the formulation of PLGA microparticles for controlled drug delivery (pp. 153-174) https://doi.org/10.1007/s40204-020-00139-y
  58. Dong et al. (2017) Experimental study on the influence of low-frequency and low-intensity ultrasound on the permeability of the Mycobacterium smegmatis cytoderm and potentiation with levofloxacin (pp. 1-8) https://doi.org/10.1016/j.ultsonch.2016.12.024
  59. Yoshida et al. (2007) Effect of poly (lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells (pp. 7-12) https://doi.org/10.1002/jbm.a.30832
  60. Koerner et al. (2019) Harnessing dendritic cells for poly (D, L-lactide-co-glycolide) microspheres (PLGA MS)—Mediated anti-tumor therapy https://doi.org/10.3389/fimmu.2019.00707